Condition: Metastatic Colorectal Cancer · Circulating Tumor DNA · Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group
This is a prospective multicenter cohort study, was designed to explore the prognostic value of ctDNA as a biomarker of disease response and recurrence or death in patients undergoing curative-intent surgical resection of Colorectal cancer liver metastasis.
This description comes directly from the study's public registry record.
Maximiliano GELLI, MD · +33(0)1 40 29 85 00 · maximiliano.gelli@gustaveroussy.fr
Marie Line GARCIA, MD · +33(0)1 40 29 85 00 · marie-line.garcia-larnicol@gercor.com.fr
Always discuss trial participation with your own doctor first.
| CHU Jean Minjoz | Besançon, France | Not Yet Recruiting |
| Institut Bergonié | Bordeaux, France | Recruiting |
| CHU Lille - Hôpital Huriez | Lille, France | Recruiting |
| Centre Léon Bérard | Lyon, France | Recruiting |
| Hôpital Bichât Claude Bernard | Paris, France | Not Yet Recruiting |
| Hôpital Cochin | Paris, France | Recruiting |
| Hôpital Pitié Salpêtrière | Paris, France | Recruiting |
| Hôpital Saint Antoine | Paris, France | Recruiting |
| Institut Mutualiste Montsouris | Paris, France | Recruiting |
| Hôpital Haut Lévêque | Pessac, France | Recruiting |
| CHU de Poitiers | Poitiers, France | Recruiting |
| CHU Rouen | Rouen, France | Not Yet Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05787197